GlassScriptPhysician profile
Wenbao Wang
NPI 1629360508
$7,899.42
in general payments reported to CMS, 2019-2025
19 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,438 · 2020: $25.30 · 2021: $64.99 · 2022: $2,093 · 2023: $1,737 · 2024: $390 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,304 · Travel and Lodging: $975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,304.32 |
| Travel and Lodging | $974.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,731.07 | 2022-2024 | Intellis Adaptivestim, Vanta Adaptivestim |
| Boston Scientific Corporation | $2,120.09 | 2019-2020 | |
| Medtronic USA, INC. | $1,103.32 | 2019 | |
| Stryker Corporation | $356.86 | 2022-2024 | Optablate, Spinejack |
| Teva Pharmaceuticals USA, INC. | $101.67 | 2019 | |
| Abbott Laboratories | $77.05 | 2021-2025 | Eterna, Proclaim |
| Epimed International, INC | $70.24 | 2019 | |
| Tersera Therapeutics LLC | $53.37 | 2019 | |
| Nevro Corp. | $49.46 | 2023-2024 | Senza |
| Abbvie INC. | $46.06 | 2023 | Botox |
| Averitas Pharma INC. | $36.19 | 2025 | Qutenza |
| Spr Therapeutics, INC | $32.48 | 2024-2025 | Sprint Pns System |
| Allergan, INC. | $21.66 | 2021 | |
| Painteq LLC | $21.17 | 2022 | |
| Globus Medical, INC. | $18.89 | 2025 | Senza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $17.78 | 2025 | Flexitouch Plus, Nimbl |
| Amgen INC. | $14.44 | 2021 | |
| Pfizer INC. | $14.20 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wenbao Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.